Work

Phase I studies with antimetabolites (A-M): Should dose escalation be driven by considerations other than body surface area (BSA)?

Year: 1999

Type: article

Source: European Journal of Cancer

DOI: 10.1016/s0959-8049(99)81561-5

Author: L. Seymour

Language: English

Topic: Statistical Methods in Clinical Trials

Subfield: Statistics and Probability

Field: Mathematics

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2043501417

FWCI:

Cites:

Cited by:

Related to: 10